A study in humans demonstrated that the mir-1539 was upregulated in whole blood of patients with recurrent myocardial infarction after percutaneous coronary intervention compared to those without recurrent events, with this differential expression remaining significant after false discovery rate correction (FDR <0.1) [Onuoha et al. DOI:10.1111/cts.13307].